Filing Flows › Indivior Pharmaceuticals (INDV) › Operating margin
Indivior Pharmaceuticals (INDV) operating margin by quarter
Indivior Pharmaceuticals' operating margin was 50.6% in Q3 2026 (third quarter 2026), +3.9 pts from Q2 2026. Over the last 7 quarters it ranged from 13.7% (Q3 2025) to 50.6% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 50.6% | +3.9 pts | +36.9 pts |
| Q2 2026 | 46.6% | +3.4 pts | +22.8 pts |
| Q1 2026 | 43.2% | +20.6 pts | +18.4 pts |
| Q4 2025 | 22.6% | +8.9 pts | — |
| Q3 2025 | 13.7% | -10.1 pts | — |
| Q2 2025 | 23.8% | -1.0 pts | — |
| Q1 2025 | 24.8% | — | — |
Q3 2026 at a glance
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Indivior Pharmaceuticals' operating margin?
Indivior Pharmaceuticals' operating margin was 50.6% in Q3 2026 (third quarter 2026), +3.9 pts from Q2 2026.
How has Indivior Pharmaceuticals' operating margin changed?
Over the last 7 quarters it ranged from 13.7% (Q3 2025) to 50.6% (Q3 2026).
Q3 2026 results → · How Indivior Pharmaceuticals makes money →